Biogen (BIIB) Tops Q3 EPS by 61c
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $216.73 -0.19%
Revenue Growth %: +4.3%
Financial Fact:
Net income attributable to Biogen Idec Inc.: 1.03B
Today's EPS Names:
OCCI, VIVO, PMCB, More
Revenue Growth %: +4.3%
Financial Fact:
Net income attributable to Biogen Idec Inc.: 1.03B
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q3 EPS of $6.31, $0.61 better than the analyst estimate of $5.70. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $3.03 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore cuts HPE rating amid 'tougher setup'
- Oracle shares fall amid job cuts
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
